Antigenic peptide compounds
US4585587A · kind A · utility
4Cited by
3References
19Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Oct 19, 1984 |
| Grant date | Apr 29, 1986 |
| Priority date | — |
| Expiry date | Oct 19, 2004 |
Classification
- Technology area (CPC Y)Emerging Cross-Sectional Technologies
- CPC primaryY10S530/806
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The novel antigenic linear peptides of this invention comprise peptides of from 4 to 13 amino acids, which are characterized by containing the sequence valine-leucine-aspartic acid-methionine. These compounds correspond with the amino acids 231 to 243, or segments thereof including sequence 239-242 of mouse LDH-C.sub.4. The coupounds have utility in vaccines for reducing the fertility of female mammals.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.